Melanotan 2 at a Glance Melanotan 2 (alpha-MSH Analog) Type: Synthetic analog of alpha-MSH | Primary Target: MC1R (melanocortin 1 receptor) | Secondary Targets: MC3R, MC4R, MC5R | Primary Effect: Skin darkening (eumelanin production) | Secondary Effects: Sexual arousal, appetite suppression | Route: Subcutaneous injection | FDA Status: Not approved | Related: PT-141 (bremelanotide), derived from MT-2 research MT-2 was originally developed at the University of Arizona in the 1990s as a potential preventive treatment for skin cancer
Analytically, we employed 10X Genomics Visium for spatial transcriptomics, which lacks true single-cell resolution compared with newer platforms such as Visium HD or Xenium
These products are supplied by their respective manufacturers and dispensed in accordance with applicable regulations
Ingham NJ, Rook V, Di Domenico F, James E, Lewis MA, Girotto G, Buniello A, Steel KP
Pro Tips from Our Dietitians Always pair protein + produce at meals for maximum fullness and muscle support